Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients

References

• Gordon C, Li CK, Isenberg DA. Systemic lupus erythematosus. Medicine 2009;38:73–80.
   Google Scholar
• Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595–602.
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni F, Laccarino L, Doria A. Environment and systemic lupus erythematosus: an overview. Autoimmunity 2005;38:465–72.
   PubMed Web of Science ®Google Scholar
• Draborg AH, Duus K, Houen G. Epstein-Barr virus and systemic lupus erythematosus. Clin Dev Immunol 2012;2012:370516.
   PubMedGoogle Scholar
• Braun DK, Dominguez G, Pellett PE. Human herpesvirus 6. Clin Microbiol Rev 1997;10:521–67.
   PubMed Web of Science ®Google Scholar
• Penkert RR, Kalejta RF. Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae 2011;2:3.
   PubMedGoogle Scholar
• Oster B, Hollsberg P. Viral gene expression patterns in human herpesvirus 6B-infected T cells. J Virol 2002;76:7578–86.
   Google Scholar
• Lin K, Ricciardi RP. The 41-kDa protein of human herpesvirus 6 specifically binds to viral DNA polymerase and greatly increases DNA synthesis. Virology 1998;250:210–19.
   Google Scholar
• Weiland KL, Oien NL, Homa F, Wathen MW. Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res 1994;34:191–206.
   PubMed Web of Science ®Google Scholar
• Kiehl A, Dorsky DI. Bipartite DN A-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function. J Virol 1995;69:1669–77.
   Google Scholar
• De Paschale M, Cagnin D, Cerulli T, Manco MT, Agrappi C, Mirri P, et al. Search for anti-EA(D) antibodies in subjects with an ‘isolated VCA IgG’ pattern. Int J Microbiol 2010;2010:695104.
   Google Scholar
• Ooka T, Turenne-Tessier MD, Stolzenberg MC. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Springer Semin Immunopathol 1991;13:233–47.
   PubMedGoogle Scholar
• Henle W, Henle G. EBV-specific serology in immunologically compromised individuals. Cancer Res 1981;41:4222–5.
   PubMed Web of Science ®Google Scholar
• Musiani M, Carpi C, Zerbini M. Rapid detection of antibodies against cytomegalovirus induced immediate early and early antigens by an enzyme linked immunosorbent assay. J Clin Pathol 1984;37:122–5.
   Google Scholar
• Draborg AH, Jorgensen JM, Muller H, Nielsen CT, Jacobsen S, Iversen LV, et al. Epstein-Barr virus early antigen diffuse (EBV EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients. Scand J Rheumatol 2012;41:280–9.
   PubMed Web of Science ®Google Scholar
• Stratta P, Canavese C, Ciccone G, Santi S, Quaglia M, Ghisetti V, et al. Correlation between cytomegalovirus infection and Raynaud’s phenomenon in lupus nephritis. Nephron 1999;82:145–54.
   PubMed Web of Science ®Google Scholar
• Esen BA, Yilmaz G, Uzun S, Ozdamar M, Aksö A, Kamali S, et al. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. Rheumatol Int 2012;32:79–83.
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, et al. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci 2009;1173:658–63.
   PubMed Web of Science ®Google Scholar
• Huggins ML, Todd I, Powell RJ. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus. Rheumatol Int 2005;25:183–7.
   PubMed Web of Science ®Google Scholar
• Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, et al. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009;18:1129–35.
   PubMed Web of Science ®Google Scholar
• Broccolo F, Drago F, Cassina G, Fava A, Fusetti L, Matteoli B, et al. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J Med Virol 2013;85:1925–34.
   PubMed Web of Science ®Google Scholar
• Su BY, Su CY, Yu SF, Chen CJ. Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol 2007;196:165–70.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, et al. Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog 2011;7:1371.
   Google Scholar
• Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD, et al. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 2006;55:799–806.
   PubMedGoogle Scholar
• Utsinger PD. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus. J Rheumatol 1976;3:175–85.
   PubMed Web of Science ®Google Scholar
• Mirzayan MJ, Schmidt RE, Witte T. Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology 2000; 39:1316–19.
   PubMed Web of Science ®Google Scholar
• Quan TE, Roman RM, Rudenga BJ, Holers VM, Craft JE. Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum 2010;62:1693–701.
   Google Scholar
• Severa M, Giacomini E, Gafa V, Anastasiadou E, Rizzo F, Corazzari M, et al. EBV Stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape. Eur J Immunol 2013;43:147–58.
   PubMed Web of Science ®Google Scholar
• Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, et al. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000;9:664–71.
   PubMed Web of Science ®Google Scholar
• Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T. Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987;70:562–9.
   PubMed Web of Science ®Google Scholar
• Schattner A. Lymphopenia in systemic lupus erythematosus: possible role of interferon. Arthritis Rheum 1983;26:1415.
   Google Scholar
• Groux H, Cottrez F, Montpellier C, Quatannens B, Coll J, Stehelin D. Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood 1997;89:4521–30.
   PubMed Web of Science ®Google Scholar
• Schneider K, Meyer-Koenig U, Hufert FT. Human cytomegalovirus impairs the function of plasmacytoid dendritic cells in lymphoid organs. PLoS One 2008;3:3482.
   PubMedGoogle Scholar
• Chang WLW, Barry PA, Szubin R, Wang D, Baumgarth N. Human cytomegalovirus suppresses type 1 interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 2009;390:330–7.
   PubMed Web of Science ®Google Scholar